Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf your Wegovy pen leaked after the injection, the most likely explanation is that a small amount of liquid remained at the injection site or in the needle — and most of it was still delivered. A visible drop after withdrawing the pen is common and does not automatically mean your dose was lost. That said, the cause matters, and a few simple technique adjustments can stop it happening again. These are prescription-only medicines reviewed clinically before being dispensed, and any persistent concerns about delivery should be raised with your prescribing team.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Most people who notice liquid on their skin after a Wegovy injection immediately worry they have lost the whole dose. That worry is understandable, semaglutide is not cheap, and the weekly rhythm of treatment makes every injection feel significant. But the reality is more reassuring than the visible drop suggests.
Wegovy is supplied in a pre-filled pen designed to deliver medicine subcutaneously, into the fatty tissue just beneath the skin. Once the button is pressed and held, the vast majority of the medicine is injected before you even begin to withdraw. What you see on the surface afterwards is almost always residual fluid from the needle hub, the entry channel in the skin, or a tiny amount that didn't travel quite deep enough because the needle was pulled away fractionally too early. The NHS semaglutide page notes that injection-site reactions and minor surface fluid are among the commonly reported experiences with this type of medicine, they are not a sign of failure.
Where genuine leakage does become a concern is if you notice a consistent wet patch and simultaneously see the pen's dose counter has not moved, or if you are experiencing none of the expected effects over several weeks. In those circumstances, speak to your prescriber rather than repeating or adjusting the dose yourself. Technique troubleshooting (not self-dosing) is the right response. If you are also noticing a firm raised area near the injection site, our page on lumps after Wegovy injections explains what causes them and when to seek advice.
The mechanics of a subcutaneous injection leave a few predictable windows where fluid can escape, and understanding them makes the fix obvious.
The most common culprit is speed. If you withdraw the pen before the full ten-second hold is complete, the plunger has not finished its travel and a small volume is still in the needle as it exits the skin. Skin tension matters too: pressing the pen firmly against the skin keeps the needle at the correct depth; lift it slightly mid-injection and the angle shifts. Pinching a skin fold and releasing it before withdrawing lets muscle movement push a trace of fluid back to the surface. Cold medicine is another factor, injecting straight from the fridge means the liquid is more viscous and slower to disperse into tissue. Leaving the pen at room temperature for around 30 minutes before use (check your Patient Information Leaflet for the exact window, as storage rules are precise) gives the medicine a better chance to absorb cleanly.
Site selection also plays a role. Injecting into the same spot repeatedly causes localised thickening (lipohypertrophy) which absorbs medicine less efficiently. Rotating methodically between the abdomen, outer thigh, and upper arm each week prevents this buildup. Our page on what to do when a Wegovy shot leaks walks through each step in more detail. For those wanting to explore the broader Wegovy experience, the Wegovy overview page covers how the medicine works and what to expect.
If the injection is already done, don't press the site or try to massage the medicine in, the tissue absorbs at its own pace and pressing can push fluid the wrong way. Apply gentle pressure with a clean cotton ball if there is any minor surface bleeding, then carry on with your day. Do not inject a second dose to compensate; semaglutide accumulates in the body over weeks and a self-added dose significantly raises the risk of side effects, particularly nausea.
For next time, the checklist is short. Hold the pen firmly against the skin, press the button fully, count a slow ten seconds, then withdraw smoothly at the same angle you entered. Let the pen do the work rather than rushing. Keeping alcohol swabs to hand for proper site preparation is a small but consistent part of good injection hygiene.
Contact your prescriber if leakage is happening consistently week after week, if you are unsure whether meaningful medicine was delivered, or if you develop persistent skin changes at injection sites. Some patients also experience fatigue in the early weeks, that is a different question, and our page on tiredness after Wegovy injections covers what is typical and what is worth flagging. You can also read more about the causes of leakage at the injection site or about partial leakage specifically. If you have not yet started treatment and are weighing your options, our treatment overview sets out what is available. The free consultation is the right starting point, a GPhC-registered prescriber reads your answers the same day and can discuss injection technique as part of ongoing aftercare.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.